Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Acquisition

21 Sep 2016 07:00

RNS Number : 3778K
Centaur Media PLC
21 September 2016
 

21 September 2016

 

Centaur Media plc

("Centaur")

 

Acquisition of specialist marketing consultancy Oystercatchers

 

Centaur Media Plc (LSE: CAU), the multi-platform business information, insight and events group, is pleased to announce that it has agreed to acquire the business and assets of Oystercatchers LLP ("Oystercatchers"). Oystercatchers will build on Centaur's Econsultancy and other marketing assets to provide an international leading consultancy in the marketing sector.

 

Oystercatchers, www.theoystercatchers.com, founded by Suki Thompson and Peter Cowie in 2008, is a consultancy helping brands to accelerate their marketing performance. Centaur's Econsultancy business www.econsultancy.com enables marketers and ecommerce professionals to succeed online with insight and data tools. The two businesses will together provide aligned services to marketing clients that improve marketing capability and performance. Limited client overlap means these two businesses offer opportunities to cross-sell services to a wider client base as well as a broader geography. Centaur's US platform will be particularly relevant to Oystercatchers' existing and future clients.

 

Oystercatchers' senior management team of Suki Thompson, Peter Cowie, Angus Crowther, Richard Robinson and Vladimir Komanicky will remain with the business and Suki Thompson will join the Centaur Executive Committee from 1 October 2016. Oystercatchers' client and agency relationships will be a valuable asset for the Centaur Group.

 

Centaur is paying up to £3.35million for Oystercatchers of which £2.2million is payable on completion. Completion is targeted for 1 October 2016 following consultation with Oystercatchers employees. The deferred consideration is contingent upon certain achievements including Oystercatchers' EBITDA for the 12 month period ending on 31 March 2017. All consideration is payable 75% in cash, 25% in Centaur shares with a two-year lock-in period on the shares.

 

Oystercatchers' turnover has grown from £1.1million in the year to 31 March 2012 to £3.4million in the year to 31 March 2016. In the year to 31 March 2016, Oystercatchers made a profit before tax of £0.6m and had gross assets of £1.1m as at that date1. Centaur expects the acquisition to be earnings enhancing in the first twelve months of ownership.

 

Suki Thompson, CEO of Oystercatchers commented:

"Oystercatchers has evolved into one of the leading specialist marketing consultancies in Europe. Joining Centaur is another stage on this journey and will help us take our expertise to many more brands globally. We are excited to be joining Centaur."

 

Andria Vidler, CEO of Centaur Media commented:

"This acquisition is a win-win for our businesses. The combination will enable Centaur to become the "go to" provider for brands seeking to drive its marketing performance. This kind of specialist acquisition is a good example of how Centaur will seek to accelerate its presence in its chosen market sectors. "

 

Enquiries

 

Centaur Media plc

Andria Vidler, Chief Executive Officer 020 7970 4000

 

Swag Mukerji, Chief Financial Officer 07941 027 130

 

Footnotes

1. Results disclosed for Oystercatchers are unaudited.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQPGUQABUPQGQU
Date   Source Headline
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company
1st Nov 202110:33 amRNSHolding(s) in Company
20th Oct 202111:54 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSTrading Update
6th Oct 20219:30 amRNSHolding(s) in Company
21st Sep 202110:31 amRNSDirector/PDMR Shareholding
7th Sep 202112:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.